BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33976609)

  • 1. Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients.
    Kriegsmann K; Pavel P; Bochtler T; Schmitt A; Sauer S; Kriegsmann M; Bruckner T; Klein S; Klüter H; Müller-Tidow C; Wuchter P
    Transfus Med Hemother; 2021 Mar; 48(2):91-98. PubMed ID: 33976609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma.
    Krummradt F; Sauer S; Pavel P; Klein EM; Schmitt A; Kriegsmann M; Jordan K; Müller-Tidow C; Goldschmidt H; Wuchter P; Kriegsmann K
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1589-1596. PubMed ID: 32428735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collection, Cryostorage, Transplantation, and Disposal of Hematopoietic Stem Cell Products.
    Kriegsmann K; Wack M; Pavel P; Schmitt A; Kriegsmann M; Bruckner T; Müller-Tidow C; Wuchter P
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):382-390. PubMed ID: 30244098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after Transplantation.
    Lisenko K; Pavel P; Kriegsmann M; Bruckner T; Hillengass J; Goldschmidt H; Witzens-Harig M; Ho AD; Wuchter P
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):684-690. PubMed ID: 28013016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell collection after intermediate-dose cytarabine in adult patients with acute myeloblastic leukemia undergoing autologous blood stem cell transplantation in first complete remission.
    de la Rubia J; Martín G; Martínez J; Lorenzo I; Sanz G; Jarque I; Moscardó F; Jiménez C; Lorente P; Camps A; Sanz MA
    Int J Hematol; 2004 Aug; 80(2):168-73. PubMed ID: 15481447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution.
    Sanz MA; de la Rubia J; Sanz GF; Martín G; Martínez J; Jarque I; Sempere A; Gomis F; Senent L; Soler MA
    J Clin Oncol; 1993 Sep; 11(9):1661-7. PubMed ID: 8102640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival.
    de la Rubia J; Sanz GF; Martín G; Martínez J; Cervera J; Solves P; Jiménez C; Arnao M; Vicente A; Jarque I; Sempere A; Sanz MA
    Haematologica; 1999 Feb; 84(2):125-32. PubMed ID: 10091410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous peripheral blood stem cell transplantation for acute leukaemias.
    de la Rubia J; Sanz MA
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):139-50. PubMed ID: 11000989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
    Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
    Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous blood stem cell transplantation-current status and issues. Fukuoka Bone Marrow Transplantation Group].
    Nagafuji K; Harada M
    Rinsho Ketsueki; 1995 Jun; 36(6):530-7. PubMed ID: 7643446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia.
    Gondo H; Harada M; Miyamoto T; Takenaka K; Tanimoto K; Mizuno S; Fujisaki T; Nagafuji K; Hayashi S; Eto T; Taniguchi S; Akashi K; Harada N; Yamasaki K; Shibuya T; Matsuishi E; Ohno Y; Makino S; Takamatsu Y; Murakawa M; Teshima T; Hirota Y; Okamura T; Kinukawa N; Niho Y
    Bone Marrow Transplant; 1997 Nov; 20(10):821-6. PubMed ID: 9404921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia.
    Takamatsu Y; Teshima T; Akashi K; Inaba S; Harada M; Niho Y
    Bone Marrow Transplant; 1994 Mar; 13(3):325-7. PubMed ID: 7515302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of cytokines in peripheral blood stem cell transplantation].
    Harada M
    Rinsho Byori; 1993 Apr; 41(4):384-9. PubMed ID: 7688833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Shimoni A; Niederwieser D; Mufti GJ; Zander AR; Arnold R; Greinix H; Cornelissen JJ; Jackson GH; Craddock C; Bunjes DW; Ganser A; Russell NH; Kyrcz-Krzemien S; Rocha V; Mohty M
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1422-9. PubMed ID: 22446014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma.
    Kai T; Ishii E; Matsuzaki A; Inaba S; Suita S; Ueda K
    Acta Paediatr Jpn; 1997 Feb; 39(1):54-60. PubMed ID: 9124054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
    Barbot C; Rice A; Vanès I; Mahon FX; Jazwiec B; Reiffers J
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):325-31. PubMed ID: 7971254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.